129 filings
Page 4 of 7
8-K
zmr0l44fx89mwdxh
29 Mar 22
IGM Biosciences Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
6:05am
8-K
3bp4hf
12 Jan 22
Results of Operations and Financial Condition
4:54pm
8-K
1f4vuj2m3 gvbxhgf0n2
4 Nov 21
IGM Biosciences Announces Third Quarter 2021 Financial Results and Provides Corporate Update
9:30am
EFFECT
h7ikdqe
20 Aug 21
Notice of effectiveness
12:15am
EFFECT
02hddape yd
20 Aug 21
Notice of effectiveness
12:15am
CORRESP
11to81p 4m9pypz
17 Aug 21
Correspondence with SEC
12:00am
CORRESP
35zhog e4x6hgd
17 Aug 21
Correspondence with SEC
12:00am
UPLOAD
t35ypm6lx qkl
16 Aug 21
Letter from SEC
12:00am
UPLOAD
ugw lmcb8upcjp
16 Aug 21
Letter from SEC
12:00am
8-K
xu9gsk xceoniy2gvxc
9 Aug 21
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:18pm
8-K
h0kx89qgl2uw s4kh3d
4 Aug 21
Departure of Directors or Certain Officers
5:21pm
8-K
g5uhawtdljy 9wu1d
13 Jul 21
Entry into a Material Definitive Agreement
5:17pm
8-K
7j0i9 zaqbqaug7
30 Jun 21
Amendments to Articles of Incorporation or Bylaws
4:26pm
8-K
8p9mo0
6 May 21
IGM Biosciences Announces First Quarter 2021 Financial Results and Provides Corporate Update
4:14pm
DEFA14A
fk7yiqxowxit3oyhl
29 Apr 21
Additional proxy soliciting materials
5:24pm